Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan and oseltamivir treatment of COVID-19 infection in home-managed patients
2020-001610-38Phase 4Completed
- Sponsor
- Slagelse Sygehus
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of irbesartan and oseltamivir in coronavirus disease 2019 (COVID-19), sponsored by Slagelse Sygehus. Primary endpoint: Hospitalization prevention. Started Apr 2020; status: completed.
02
Drugs
irbesartanoseltamivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001610-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001610-38.